JEPI vs XLV
JPMorgan Equity Premium Income ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.35% for JEPI.
- • JEPI pays a higher dividend yield (7.93%).
Side-by-side metrics
| Metric | JEPI | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.08% |
Dividend yield Trailing 12-month yield. | 7.93% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $46.16B | $49.10B |
YTD return | 7.47% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.40 | 0.41 |
P/E ratio | 24.39 | 30.63 |
Last price | $58.17 | $187.94 |
Inception | — | — |
Issuer | JPMorgan | State Street |
JEPI top holdings
| MA | Mastercard Inc Class A | 1.96% |
| AAPL | Apple Inc | 1.94% |
| MSFT | Microsoft Corp | 1.94% |
| V | Visa Inc Class A | 1.86% |
| NEE | NextEra Energy Inc | 1.80% |
| JNJ | Johnson & Johnson | 1.80% |
| EOG | EOG Resources Inc | 1.78% |
| MMM | 3M Co | 1.78% |
| JIMXX | JPMorgan Prime Money Market IM | 1.76% |
| ABBV | AbbVie Inc | 1.76% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About JEPI
JEPI (JPMorgan Equity Premium Income ETF) is Active equity income with covered-call overlay. Managed by JPMorgan, the fund carries $46.2B in assets under management, an expense ratio of 0.35%, a dividend yield of 7.93%. Its largest holding is Mastercard Inc Class A (MA), which represents 2.0% of the portfolio. Real Estate is the fund's largest sector exposure at 2.3%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.